Italia markets closed

ALR Technologies Inc. (ALRTF)

Other OTC - Other OTC Prezzo differito. Valuta in USD.
Aggiungi a watchlist
0,0200+0,0000 (+0,01%)
Alla chiusura: 11:45AM EDT
Schermo intero
I prezzi di scambio non provengono da tutti i mercati
Chiusura precedente0,0200
Aperto0,0200
DenaroN/D x N/D
LetteraN/D x N/D
Min-Max giorno0,0200 - 0,0200
Intervallo di 52 settimane0,0113 - 0,0499
Volume4.800
Media Volume20.048
Capitalizzazione12,644M
Beta (5 anni mensile)0,35
Rapporto PE (ttm)N/D
EPS (ttm)-0,0100
Prossima data utiliN/D
Rendimento e dividendo (futuro)N/D (N/D)
Data ex dividendoN/D
Stima target 1AN/D
  • GlobeNewswire

    ALR Technologies Announces Canadian Launch Plans for the GluCurve Pet CGM

    SINGAPORE, Aug. 07, 2023 (GLOBE NEWSWIRE) -- ALR Technologies SG Ltd. (“ALRT” or the “Company”) (OTCQB:ALRTF), the diabetes management company, announces plans to launch the GluCurve Pet CGM (“GluCurve”) in Canada during Q3 2023 with a direct to veterinarian clinic sales model through GluCurve.ca. The Canadian website will go live on or before August 28th when the Company expects to begin taking orders. The inventory from the purchase order announced on June 1, 2023 will now be used for the Cana

  • GlobeNewswire

    ALR Technologies Announces Second Generation GluCurve Pet CGM for Diabetic Cats and Dogs

    SINGAPORE, June 01, 2023 (GLOBE NEWSWIRE) -- ALR Technologies SG Ltd. (“ALRT”) (OTCQB:ALRTF), the diabetes management company, announces the issuance of a purchase order for the first shipment of second generation CGM hardware used in the GluCurve Pet CGM. The shipment is expected to be delivered to ALRT’s distributor in early Q3 with a sales value of USD $350,000. “We quickly sold out of inventory during our soft launch in January due to tremendous interest in the GluCurve Pet CGM from veterina